Total parenteral nutrition in the newborn

Total Parenteral Nutrition in the Newborn 265 Table II. Endogenous Fuel Composition of Man... 

Total Parenteral Nutrition in the Newborn Table III. Diagnosis of Infants Receiving TPN in the Neonatal Intensive Care Unit at the Hospital for Sick Children (Toronto) During 6 Mo of 1982 ... 

Parenteral used for seizure prevention and control in severe preeclampsia or eclampsia without deleterious CNS depression in the mother, fetus, or newborn as replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia to correct or prevent hypomagnesemia by addition to total parenteral nutrition admixture hypertension, encephalopathy, and convulsions in children with acute nephritis inhibition of premature labor as treatment of life-threatening ventricular arrhythmias for prevention and treatment of nutritional magnesium deficiency and as a laxative. 

In a prospective cohort study including 24 infants, the incidence and risk factors of parenteral nutrition-associated liver disease (PNALD) was determined. Eight infants developed PNALD. The concluded that the duration of enteral starvation, gastrointestinal surgery, duration of enteral nutrition, maximum caloric and carbohydrate intakes were significant risks of PNALD in newborn infants [lob ll. In a retrospective review of the safety and efficacy of PN among 105 paediatric patients with bum injuries (>30% total-body sxuface area), no respiratory or blood infections were observed with the use of parenteral nutrition, and the overall mortality rate was 4% [107 ]. 

---